Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Developmental toxicity / teratogenicity

Currently viewing:

Administrative data

developmental toxicity
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
key study
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Well documented scientfically sound study similar to OECD guidelines with sufficient information provided on materials and methods to evaluate results. Due to lower water solubility and lower toxicity for the target substance (tungsten metal) compared to the source substance (sodium tungstate), the resulting read-across from the source substance to the target substance is appropriate as a conservative estimate of potential toxicity for this endpoint. In addition, read-across is appropriate because the classification and labelling is more protective for the source substance than the target substance, the PBT/vPvB profile is the same, and the dose descriptors are, or are expected to be, lower for the source substance. For more details, refer to the attached description of the read-across approach.
Reason / purpose for cross-reference:
reference to same study

Data source

Reference Type:
Neurobehavioral effects of sodium tungstate exposure on rats and their progeny.
McInturf SM et al.
Bibliographic source:
Neurotoxicology and Teratology, doi:10.1016/

Materials and methods

Test guideline
equivalent or similar to guideline
other: EPA OPPTS 870.3650 "Combined Repeated Dose Toxicity Study with the Reproduction/Developmental Toxicity Study
The protocol was extended beyond the minimum 54 days of treatment to accomodate evaluation of the development of the offspring through postnatal day 20 as well as their dams following the last dose on day 70.
GLP compliance:
not specified

Test material

Constituent 1
Chemical structure
Reference substance name:
Disodium wolframate
EC Number:
EC Name:
Disodium wolframate
Cas Number:
Molecular formula:
Disodium dioxido(dioxo)tungsten
Constituent 2
Reference substance name:
Sodium tungstate
Sodium tungstate
Details on test material:
- Name of test material (as cited in study report): Sodium tungstate dihydrate (Reported as 10213-10-2)
- Source: Fisher Scientific
- Analytical purity: >98%

Test animals

Details on test animals or test system and environmental conditions:
- Source: Charles River Laboratories (Wilmington, MA)
- Age at study initiation: 8 weeks
- Housing: The adults (e.g., P1) were singly housed (except during mating)
- Acclimation period: 14 days

Administration / exposure

Route of administration:
oral: gavage
other: deionized water
Details on exposure:
PREPARATION OF DOSING SOLUTIONS: The powder readily dissolved in a deionized water (diH2O) vehicle for the concentrations used in this study at 5 mg/mL and 125 mg/mL. The solution was concentrated to administer a volume of 1 mL/kg body weight not to exceed 2 mL. Fresh solution was made daily and administered via oral gavage

- Justification for use and choice of vehicle (if other than water): no data
- Concentration in vehicle: no data
- Amount of vehicle (if gavage): no data
- Lot/batch no. (if required): no data
- Purity: no data
Analytical verification of doses or concentrations:
not specified
Details on analytical verification of doses or concentrations:
Concentrations of the tungstate anion were determined using inductively coupled plasma mass spectrometry (ICP-MS).
Details on mating procedure:
- Impregnation procedure: cohoused
- If cohoused:
- M/F ratio per cage: not specified
- Length of cohabitation: 14 days
- Verification of same strain and source of both sexes: not specified
- Proof of pregnancy: vaginal plug referred to as day 1 of pregnancy
Duration of treatment / exposure:
70 days
Frequency of treatment:
daily pre- and postnatal exposure
Doses / concentrationsopen allclose all
Doses / Concentrations:
5 mg/kg/day
actual ingested
Doses / Concentrations:
125 mg/kg/day
actual ingested
No. of animals per sex per dose:
120 males and 120 females (40 per treatment group)
Control animals:
yes, concurrent vehicle
Details on study design:
In order to ensure a total of 70 days exposure, adults were dosed for any additional days necessary following weaning. Prenatal pup exposure was from sodium tungstate crossing through the placenta and postnatal exposure was indirect via dams' milk.


Maternal examinations:
- Time schedule: Throughout the exposure period, dams and the males used for mating were observed for clinical signs of toxicity.

- Time schedule for examinations: Pregnant dams were weighed on gestation days (GD) 1, 10, 15 and 20, and gestational weight gain and gestation length were recorded.


Ovaries and uterine content:
no data
Fetal examinations:
- External examinations: No data
- Soft tissue examinations: Yes: control and high dose pups
- Skeletal examinations: No data
- Head examinations: Yes
All measures were analyzed using ANOVA. Repeated measures ANOVA were used where appropriate. All animals in the pre-weanling litter were tested for righting reflex and separation distress so the litter was used as the unit of analysis for the ANOVA. The fiducial limit was pb 0.05 and post-hoc comparisons were performed using Tukey's HSD analysis for pair-wise comparisons as appropriate.

Results and discussion

Results: maternal animals

Maternal developmental toxicity

Details on maternal toxic effects:
Maternal toxic effects:yes

Details on maternal toxic effects:
Astatistically significant difference was found for one of the treatment groups on measures of reproductive toxicity. In the dams, average gestation duration was longer for the 125 mg/kg/day dose group than for the control and 5 mg/kg/day groups. Average gestational weight gain did not differ across treatments.

Effect levels (maternal animals)

Dose descriptor:
Effect level:
125 mg/kg bw/day (nominal)
Based on:
test mat.
Basis for effect level:
other: developmental toxicity

Results (fetuses)

Details on embryotoxic / teratogenic effects:
Embryotoxic / teratogenic effects:yes

Details on embryotoxic / teratogenic effects:
There were no differences in average number of pups born.
All pups were inspected for physical birth defects, including missing digits, however, none were found.
The high dose group demonstrated a greater number of ultrasonic distress vocalizations when separated from the dam and littermates.
Righting reflex: For righting reflex, a significant effect of sex was found (P<0.05) where males were faster (9.6±1.3 s) than females (14.5±1.6 s). No significant effects related to dose were found.

Fetal abnormalities

not specified

Overall developmental toxicity

Developmental effects observed:
not specified

Applicant's summary and conclusion

The tests were selected to provide a screening-level assessment of a range of neurobehavioral capacities in sodium tungstate exposed dams and their offspring. The tests evaluated reflexive responding, emotionality and spatial learning and memory. Exposure-related effects were observed both in the dams and developing pups, and for low and high dose exposures. Overall, the results of this study suggest pre- and postnatal oral exposure to sodium tungstate may produce subtle neurobehavioral effects in offspring related to motor activity and emotionality. The NOAEL for developmental toxicity was deemed to be 125 mg/kg/day.